Por: RTTNews Health January 02, 2024
Soligenix, Inc. () announced a publication describing the preclinical efficacy of a single-vial, bivalent vaccine providing protection against both Sudan ebolavirus and Marburg marburgvirus infections. The company said the published paper describes the potency of the bivalent formulation against both viruses, showing 100% protection in the most rigorous non-human primate challenge models.Soligenix is a late-stage biopharmaceutical company... + full article
Time USA Health June 15, 2023
When it comes to a disease as complex as Alzheimer’s, scientists have found a number of factors that can contribute to your risk, from genes to circulatory issues, inflammation, and lifestyle behaviors. In a new published in Science Translational Medicine, researchers from... + más
How To Spot The Early Signs Of Alzheimer's | Newsweek
Here's what disease does to brain, signs to look for: Alzheimer's Q&A | The Advocate
RTTNews USA Health April 19, 2023
The U.S. Food and Drug Administration said it has amended the emergency use authorizations or EUAs of COVID-19 bivalent mRNA vaccines of ModernaTX Inc. and Pfizer-BioNTech to simplify the vaccination schedule for most individuals.With the changes, the current bivalent vaccines,... + más
FDA Authorizes Changes To Simplify Use Of Moderna, Pfizer Bivalent COVID-19 Vaccines | RTTNews
FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5 | RTTNews
Ars Technica USA Science April 19, 2023
Navigate Filter by topic Settings Front page layout Site theme - Apr 18, 2023 8:49 pm UTC / A pharmacist holds a bottle containing Moderna's bivalent COVID-19 vaccine. Share this story The Food and Drug Administration on Tuesday , retiring the original monovalent versions... + más
First efficacy data on bivalent boosters shows they work against infection | Ars Technica
RTTNews USA Health March 15, 2023
The U.S. Food and Drug Administration has authorized bivalent Pfizer-BioNTech covid-19 vaccine as booster dose for certain children 6 months through 4 years of age.In a statement, the regulator said it has amended the emergency use authorization or EUA of the Pfizer-BioNTech... + más
Amid pathetic uptake, FDA green lights confusing COVID vaccine update for kids | Ars Technica
Ars Technica USA Science November 23, 2022
Navigate Filter by topic Settings Front page layout Site theme - Nov 22, 2022 6:55 pm UTC / Dr. Anthony Fauci, White House chief medical adviser, speaks alongside COVID-19 Response Coordinator Dr. Ashish Jha during a briefing on COVID-19 at the White House on November 22, 2022,... + más
Kids 5-11 can now get the bivalent, BA.5-targeting COVID booster | Ars Technica
CDC study: Omicron-specific boosters show modest benefit compared to earlier vaccines | Portland Press Herald
About iurex | Privacy Policy | Disclaimer |